📰 Numinus Bioscience News
Page 7 - Numinus Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Numinus Bioscience. Real-time updates on events, politics, business and more.
January 19, 2022
/PRNewswire/ -- After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical...
January 17, 2022
Numinus Wellness has submitted CTA to Health Canada to commence Phase I trial of NBIO-01 for psychedelic-assisted therapies.
January 14, 2022
/PRNewswire/ - Numinus Wellness Inc. ("Numinus") (TSX: NUMI), a leader in psychedelics-focused mental healthcare, is pleased to announce that it has formally...
January 14, 2022
The formulation has been developed to stably deliver psilocybin and other synergistic compounds and will be studied for safety and...
January 14, 2022
/PRNewswire/ - Numinus Wellness Inc. ("Numinus") (TSX: NUMI), a leader in psychedelics-focused mental healthcare, is pleased to announce that it has formally...
January 14, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
January 14, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
January 14, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
January 14, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
January 14, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires